Unused Pharmaceuticals Common After Cataract Surgery
Study shows both financial, environmental costs to unused pharmaceuticals across surgical sites
Read MoreAug 12, 2019
Study shows both financial, environmental costs to unused pharmaceuticals across surgical sites
Read MoreAug 12, 2019
Study suggests aspirin is hepatoprotective, improves survival by reducing liver inflammation
Read MoreAug 10, 2019
A study has found the incidence of hospitalizations for upper gastrointestinal tract bleeding is...
Read MoreAug 9, 2019
Nearly 30 years ago, Sally Helgesen wrote what’s considered one of the first books on women’s...
Read MoreAug 9, 2019
Perioperative opioid fills linked to risk of return visit for constipation but not pain, dehydration or hemorrhage
Read MoreAug 8, 2019
Considerable proportion of increased CHF, IHD, and stroke risk mediated by NSAID use
Read MoreAug 7, 2019
22 percent of increased total spending due to higher per-unit cost of existing drugs
Read MoreAug 6, 2019
Poor outcomes include higher mortality, longer hospital stay, and greater risk for C. difficile infection
Read MoreAug 5, 2019
The following was originally posted by Kelly Cawcutt, MD, to the University of Nebraska Medical...
Read MoreAug 2, 2019
Review shows evidence that brand-brand competition was mediated by quality of competing drugs
Read MoreAug 2, 2019
Patients’ perceptions of pain, pain medication may affect prescribing practices
Read MoreAug 1, 2019
Plan will start by exploring options for importing certain prescription drugs to lower costs for Americans
Read MoreAug 1, 2019
Progression-free, overall survival improved in the ibrutinib-rituximab group at three years
Read MoreAug 1, 2019
Preeclampsia the single most important risk factor for transfusion reactions in this patient population
Read MoreJul 30, 2019
The month of July 2019 just breezed through. For those who started their internship/fellowship/new...
Read MoreJul 30, 2019
New Federal Employee Health Benefits Program rules are meant to prevent overprescribing
Read MoreJul 30, 2019
In pay-to-delay deals, generic drug makers paid to keep cheaper version of the drug off market
Read MoreJul 29, 2019
When Zolgensma was approved, maker Novartis said it expected insurance companies to cover the cost
Read MoreJul 26, 2019
New research was presented at IAS 2019, the 10th International AIDS Society Conference on HIV...
Read MoreJul 25, 2019
Educational videos produced the highest rate of acceptability and knowledge
Read More